Figure 2.
Trial profile. A total of 83 patients were evaluated for eligibility in this study, and after exclusion, 57 patients were enrolled. After exclusion of dropout (n=6) and termination (n=1) for specific reasons, 51 patients were analyzed for the primary outcome and 50 patients were analyzed for the secondary outcomes. (Designed in Microsoft Word and converted to JPG).